Woodline Partners’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.5M Buy
940,700
+11,598
+1% +$142K 0.06% 392
2025
Q1
$10.2M Buy
+929,102
New +$10.2M 0.07% 356